Related Experiment Video
Updated: Sep 7, 2025

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the
Tiziana Siciliano1, Ulrich Sommer2, Alicia-Marie K Beier1,3
1Department of Urology, Technische Universität Dresden, 01307 Dresden, Germany.
Abstract:
The androgen receptor (AR) plays a central role in prostate, muscle, bone and adipose tissue. Moreover, dysregulated AR activity is a driving force in prostate cancer (PCa) initiation and progression. Consequently, antagonizing AR signalling cascades via antiandrogenic therapy is a crucial treatment option in PCa management. Besides, very high androgen levels also inhibit PCa cells' growth, so this effect could also be applied in PCa therapy. However, on the molecular and cellular level, these mechanisms have hardly been investigated so far. Therefore, the present study describes the effects of varying androgen concentrations on the viability of PCa cells as well as localization, transactivation, and protein stability of the AR. For this purpose, cell viability was determined via WST1 assay. Alterations in AR transactivity were detected by qPCR analysis of AR target genes. A fluorescent AR fusion protein was used to analyse AR localization microscopically. Changes in AR protein expression were detected by Western blot. Our results showed that high androgen concentrations reduce the cell viability in LNCaP and C4-2 cell lines. In addition, androgens have been reported to increase AR transactivity, AR localization, and AR protein expression levels. However, high androgen levels did not reduce these parameters. Furthermore, this study revealed an androgen-induced increase in AR protein synthesis. In conclusion, inhibitory effects on cell viability by high androgen levels are due to AR downstream signalling or non-genomic AR activity. Moreover, hormonal activation of the AR leads to a self-induced stabilization of the receptor, resulting in increased AR activity. Therefore, in clinical use, a therapeutic reduction in androgen levels represents a clinical target and would lead to a decrease in AR activity and, thus, AR-driven PCa progression.
Insights
High androgen levels inhibit prostate cancer cell growth by increasing androgen receptor (AR) activity and stability. Therapeutic reduction of androgens may decrease AR activity, slowing prostate cancer progression.
Area of Science:
- Androgen receptor (AR) signaling in prostate cancer
- Molecular mechanisms of prostate cancer progression
Background:
- The androgen receptor (AR) is crucial in prostate, muscle, bone, and adipose tissues.
- Dysregulated AR activity drives prostate cancer (PCa) initiation and progression.
- Antiandrogenic therapy is a key PCa treatment, but high androgens also inhibit PCa cells.
Purpose of the Study:
- Investigate the effects of varying androgen concentrations on PCa cell viability.
- Analyze AR localization, transactivation, and protein stability under different androgen levels.
- Elucidate the molecular mechanisms behind high androgen-induced inhibition of PCa cell growth.
Main Methods:
- Cell viability assessed using WST1 assay.
- AR transactivity evaluated by qPCR analysis of AR target genes.
- AR localization visualized using fluorescent AR fusion protein microscopy.
- AR protein expression changes detected by Western blot.
Main Results:
- High androgen concentrations reduced viability in LNCaP and C4-2 PCa cell lines.
- Androgens increased AR transactivity, localization, and protein expression.
- High androgen levels did not decrease these AR parameters but induced increased AR protein synthesis.
- Inhibitory effects on cell viability are linked to AR downstream signaling or non-genomic AR activity.
Conclusions:
- Hormonal activation of the AR leads to self-induced receptor stabilization and increased activity.
- High androgen levels inhibit PCa cell viability through AR downstream signaling or non-genomic activity.
- Therapeutic reduction of androgen levels is a potential clinical strategy to decrease AR activity and slow PCa progression.
More Related Videos
Related Concept Videos
Internal Receptors
Intracellular Hormone Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Signal Transduction: Overview
Typically, signal transduction involves three...

